MET and non-small cell lung carcinoma: EGFR and cMET are client proteins of HSP90.24, 25, 26 We therefore hypothesized that N19 could act as an HSP90 inhibitor to kill EGFR-mutated NSCLC cells via degradation of EGFR and cMET proteins by ubiquitin proteasomes.